Targeted phage hunting to specific Klebsiella pneumoniae clinical isolates is an efficient antibiotic resistance and infection control strategy
Microbiology Spectrum · 2024
DOI: 10.1128/spectrum.00254-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Celia Ferriol-González und 7 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Biología Integrativa de Sistemas, Universitat de València-CSIC, Paterna, Spain. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Klebsiella Infections, Bacteriophages, Phage Therapy. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Ministerio de Ciencia e Innovación (MCIN), GVA | Conselleria de Innovación, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana (CIUCSD).
Themen: Nosokomiale Infektionen
Abstract (Originalsprache)
Klebsiella pneumoniae is one of the most threatening multi-drug-resistant pathogens today, with phage therapy being a promising alternative for personalized treatments. However, the intrinsic capsule diversity in Klebsiella spp. poses a substantial barrier to the phage host range, complicating the development of broad-spectrum phage-based treatments. Here, we have isolated and genomically characterized phages capable of infecting each of the acquired 77 reference serotypes of Klebsiella spp. , including capsular types widespread among high-risk K. pneumoniae clones causing nosocomial infections. We demonstrated the possibility of isolating phages for all capsular types in the collection, revealing high capsular specificity among taxonomically related phages, in contrast to a few phages that exhibited broad-spectrum infection capabilities. To decipher the determinants of the specificity of these phages, we focused on their receptor-binding proteins, with particular attention to depolymerases. We also explored the possibility of designing a broad-spectrum phage cocktail based on phages isolated in reference capsular-type strains and determining the ability to lyse relevant clinical isolates. A combination of 12 phages capable of infecting 55% of the reference Klebsiella spp. serotypes was tested on a panel of carbapenem-resistant K. pneumoniae clinical isolates. Thirty-one percent of isolates were susceptible to the phage cocktail. However, our results suggest that in a highly variable encapsulated bacterial host, phage hunting must be directed to the specific Klebsiella isolates. This work is a step forward in the understanding of the complexity of phage–host interactions and highlights the importance of implementing precise and phage-specific strategies to treat K. pneumoniae infections worldwide. IMPORTANCE The emergence of resistant bacteria is a serious global health problem. In the absence of effective treatments, phages are a personalized and effective therapeutic alternative. However, little is still known about phage–host interactions, which are key to implementing effective strategies. Here, we focus on the study of Klebsiella pneumoniae, a highly pathogenic encapsulated bacterium. The complexity and variability of the capsule, where in most cases phage receptors are found, make it difficult for phage-based treatments. Here, we isolated a large collection of Klebsiella phages against all the reference strains and in a cohort of clinical isolates. Our results suggest that clinical isolates represent a challenge, especially high-risk clones. Thus, we propose targeted phage hunting as an effective strategy to implement phage-derived therapies. Our results are a step forward for new phage-based strategies to control K. pneumoniae infections, highlighting the importance of understanding phage–host interactions to design personalized treatments against Klebsiella spp.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Biología Integrativa de Sistemas, Universitat de València-CSIC, Paterna, Spain.
- Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Sevilla, Spain.
- Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen Macarena-CSIC-Universidad de Sevilla, Sevilla, Spain.
- CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
- Laboratorio de Referencia e Investigación en Resistencia a Antibióticos e Infecciones Relacionadas con la Asistencia Sanitaria, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
ORCID-Profile: Silvia García-Cobos, Rafael Sanjuán, Pilar Domingo-Calap
Förderung
- European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
- Ministerio de Ciencia e Innovación (MCIN)
- GVA | Conselleria de Innovación, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana (CIUCSD)
- Universidad de Valencia
- Comunidad de Madrid (Community of Madrid)
Zitieren
APA
Ferriol-González, C., Concha-Eloko, R., Bernabéu-Gimeno, M., Fernández-Cuenca, F., Cañada-García, J. E., García-Cobos, S., Sanjuán, R., & Domingo-Calap, P. (2024). Targeted phage hunting to specific Klebsiella pneumoniae clinical isolates is an efficient antibiotic resistance and infection control strategy. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00254-24
Vancouver
Ferriol-González C, Concha-Eloko R, Bernabéu-Gimeno M, Fernández-Cuenca F, Cañada-García JE, García-Cobos S, et al. Targeted phage hunting to specific Klebsiella pneumoniae clinical isolates is an efficient antibiotic resistance and infection control strategy. Microbiology Spectrum. 2024. doi:10.1128/spectrum.00254-24
BibTeX
@article{FerriolGonzlez2024,
author = {Ferriol-González, Celia and Concha-Eloko, Robby and Bernabéu-Gimeno, Mireia and Fernández-Cuenca, Felipe and Cañada-García, Javier E and García-Cobos, Silvia and Sanjuán, Rafael and Domingo-Calap, Pilar},
title = {Targeted phage hunting to specific Klebsiella pneumoniae clinical isolates is an efficient antibiotic resistance and infection control strategy},
journal = {Microbiology Spectrum},
year = {2024},
doi = {10.1128/spectrum.00254-24}
}
EUVIMED